Walleye Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,764
| Closed | -$1.05M | – | 2141 |
|
|
2025
Q1 | $1.05M | Sell |
26,764
-182,132
| -87% | -$7.12M | ﹤0.01% | 826 |
|
|
2024
Q4 | $11.3M | Buy |
+208,896
| New | +$11.3M | 0.03% | 234 |
|
|
2024
Q3 | – | Sell |
-86,278
| Closed | -$3.79M | – | 2724 |
|
|
2024
Q2 | $3.79M | Sell |
86,278
-50,151
| -37% | -$2.21M | 0.01% | 558 |
|
|
2024
Q1 | $6.85M | Buy |
+136,429
| New | +$6.85M | 0.01% | 351 |
|
|
2023
Q4 | – | Sell |
-67,926
| Closed | -$3.87M | – | 2680 |
|
|
2023
Q3 | $3.87M | Buy |
+67,926
| New | +$3.87M | 0.01% | 446 |
|